Dapagliflozin and sacubitril on myocardial microperfusion in patients with post-acute myocardial infarction heart failure and type 2 diabetes

Table 1 Comparison of general characteristics between the two groups

Item	Control group (n = 47)	Observation group (n = 51)	t/F	P value
Sex (M/F)	26 (55.32)/21 (44.68)	28 (54.90)/23 (45.10)	0.002	0.967
Age (year)	63.92 ± 9.85	65.01 ± 10.21	-0.537	0.593
BMI (kg/m2)	26.12 ± 2.56	26.64 ± 2.67	-0.982	0.328
HR (beat/min)	80.11 ± 9.14	78.95 ± 8.78	0.641	0.523
T2DM course (years)	8.96 ± 2.47	8.74 ± 2.19	0.467	0.641
Time from onset to operation (hours)	5.21 ± 1.91	5.04 ± 1.97	0.433	0.666
Killip classification (I-IV)			0.703	0.704
Grade II	11 (23.40)	10 (19.61)
Grade III	28 (59.57)	29 (56.86)
Grade IV	8 (17.02)	12 (23.53)

Control group: Noxital treatment; Observation group: Dapagliflozin combined with noxital; BMI: Body mass index; HR: Heart rate.